Chief Scientific Officer @ (July 2020 - June 2025)
Chief Scientific Officer @ (January 2011 - January 2013)
Director Clinical Development and Director Preclinical R and D @ (January 2008 - January 2011)
Head of Biology @ (January 2004 - January 2008)
Senior Scientist, Coordinator Bioassay-Unit @ (January 2001 - January 2004)
Postdoctoral Scientist @ Novartis Research Institute (January 1998 - January 2001)
Daniel Bock Education
Medical School Hannover / University Hannover
PhD
Daniel Bock Skills
Team Building
Clinical Trials
CRO
Psoriasis
Start Ups
Business Development
Regulatory Affairs
Immunology
Inflammation
Strategic Planning
Medical Devices
Drug Discovery
Asthma
Lifesciences
COPD
Drug Development
Clinical Development
Respiratory Disease
Leukocyte Trafficking
Respiratory Therapy
Pharmacology
Management
Admet
Selectins
Biomarkers
R&D
Bimosiamose
Daniel Bock Summary
Daniel Bock, based in Germany, is currently a CSO and COO at APTA Therapeutics GmbH. Daniel Bock brings experience from previous roles at Independent Expert & Consultant, sterna biologicals GmbH and Revotar Biopharmaceuticals AG. Daniel Bock holds a PhD @ Medical School Hannover / University Hannover. With a robust skill set that includes Team Building, Clinical Trials, CRO, Psoriasis, Start Ups and more. Daniel Bock has 1 emails on RocketReach.
Looking for a different Daniel Bock?
Find contact details for 700 million professionals.